| |
 |
Editorial:Hot Topic: [Exploiting Multivalency in Drug Design(Executive Editor: Diego Munoz-Torrero)]
|
| |
|
pp.585-586 (2) Author: Diego Munoz-Torrero
|
| |
|
|
| |
|
Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges
|
| |
|
pp.587-600 (14) Authors: Richard Morphy, Zoran Rankovic
|
| |
|
|
| |
|
MTDL Design Strategy in the Context of Alzheimer's Disease: From Lipocrine to Memoquin and Beyond
|
| |
|
pp.601-613 (13) Authors: M. L. Bolognesi, M. Rosini, V. Andrisano, M. Bartolini, A. Minarini, V. Tumiatti, C. Melchiorre
|
| |
|
|
| |
|
Pharmacodynamic Hybrids Coupling Established Cardiovascular Mechanisms of Action with Additional Nitric Oxide Releasing Properties
|
| |
|
pp.614-636 (23) Authors: Alma Martelli, Maria Cristina Breschi, Vincenzo Calderone
|
| |
|
|
| |
|
Multivalent & Multifunctional Ligands to β-Amyloid
|
| |
|
pp.637-658 (22) Authors: YoungSoo Kim, Ji Hoon Lee, Jiyeon Ryu, Dong Jin Kim
|
| |
|
|
| |
|
Novel Classes of Dimer Antitumour Drug Candidates
|
| |
|
pp.659-674 (16) Authors: Larry M.C. Chow, Tak Hang Chan
|
| |
|
|
| |
|
Designer Peptides: Learning from Nature
|
| |
|
pp.675-681 (7) Authors: A. Shrivastava, A. D. Nunn, M. F. Tweedle
|
| |
|
|
| |
|
Design of Multivalent Ligand Targeting G-Protein-Coupled Receptors
|
| |
|
pp.682-718 (37) Authors: Zhili Liu, Jing Zhang, Ao Zhang
|
| |
|
|
| |
|
Multivalent-Based Drug Design Applied to Serotonin 5-HT4 Receptor Oligomers
|
| |
|
pp.719-729 (11) Authors: Frank Lezoualc'h, Ralf Jockers, Isabelle Berque-Bestel
|
| |
|
|
